Cofoe Medical Technology Co., Ltd. (COFOE MEDICAL, HKEx: 01187) submitted a Next Day Disclosure Return on 1 September 2026 detailing recent movements in its share capital and treasury shares.

As of the opening balance on 31 August 2026, the company had 208.90 million issued A-shares, comprising 201.70 million outstanding shares and 7.20 million treasury shares.

Latest transaction: on 1 September 2026, Cofoe Medical repurchased 574,000 A-shares on the Shenzhen Stock Exchange at prices between RMB 48.39 and RMB 50.20, for a total consideration of RMB 28.43 million. The average purchase price was RMB 49.54 per share. All repurchased shares are designated for cancellation.

Cumulative activity: between 22 July and 1 September 2026, the company bought back 2.52 million shares that are yet to be cancelled. This volume represents approximately 1.24 % of the outstanding share base prior to the first repurchase and was executed at session-weighted average prices ranging from RMB 49.54 to RMB 54.19.

Issued share capital will remain at 208.90 million shares until the cancellation of the repurchased shares is completed.